Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $512.33 | 2 | 64.6% |
| Food and Beverage | $281.14 | 13 | 35.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $604.17 | 4 | $0 (2018) |
| ABBVIE INC. | $64.03 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $45.55 | 4 | $0 (2017) |
| Astellas Pharma US Inc | $33.27 | 2 | $0 (2017) |
| Bioventus LLC | $22.50 | 1 | $0 (2018) |
| Nestle HealthCare Nutrition Inc. | $12.71 | 1 | $0 (2021) |
| Horizon Pharma plc | $11.24 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $15.20 | 1 | ABBVIE INC. ($15.20) |
| 2021 | $12.71 | 1 | Nestle HealthCare Nutrition Inc. ($12.71) |
| 2019 | $48.83 | 1 | AbbVie, Inc. ($48.83) |
| 2018 | $626.67 | 5 | Stryker Corporation ($604.17) |
| 2017 | $90.06 | 7 | Merck Sharp & Dohme Corporation ($45.55) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/30/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $48.83 | General |
| 05/11/2018 | Stryker Corporation | REUNION (Device) | Travel and Lodging | Cash or cash equivalent | $299.70 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 05/11/2018 | Stryker Corporation | REUNION (Device) | Food and Beverage | Cash or cash equivalent | $53.57 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 05/11/2018 | Stryker Corporation | REUNION (Device) | Food and Beverage | Cash or cash equivalent | $38.27 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 04/19/2018 | Stryker Corporation | REUNION (Device) | Travel and Lodging | Cash or cash equivalent | $212.63 | General |
| Category: TRAUMA & EXTREMETIES | ||||||
| 01/29/2018 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Not Applicable | ||||||
| 05/30/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Infectious Diseases | ||||||
| 04/20/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/18/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: DUEXIS | ||||||
| 02/09/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/08/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Infectious Diseases | ||||||
| 01/12/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/03/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. John Collins, M.D
Dr. John Collins, M.D is a Specialist healthcare provider based in Independence, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912990227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Collins, M.D has received a total of $793.47 in payments from pharmaceutical and medical device companies, with $15.20 received in 2022. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($512.33).
Practice Information
- Specialty Specialist
- Location Independence, MO
- Active Since 08/23/2005
- Last Updated 02/10/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1912990227
Products in Payments
- REUNION (Device) $604.17
- ZERBAXA (Drug) $34.66
- Cresemba (Drug) $33.27
- GELSYN 3 (Device) $22.50
- VRAYLAR (Drug) $15.20
- ZENPEP (Drug) $12.71
- DUEXIS (Drug) $11.24
- NOXAFIL (Drug) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Independence
Dr. Timothy Hall, M.d, M.D
Specialist — Payments: $117,199
Dr. Ajay Singh, Md, MD
Specialist — Payments: $74,065
Dr. Arthur Brock, Md, MD
Specialist — Payments: $34.91
Dr. Sol Dubin, M.d, M.D
Specialist — Payments: $33.72
Dr. Amy Trout, M.d, M.D
Specialist — Payments: $32.63
Dr. Burnell Landers, Md, MD
Specialist